CEFAZOLIN AND DEXTROSE Drug Patent Profile
✉ Email this page to a colleague
When do Cefazolin And Dextrose patents expire, and what generic alternatives are available?
Cefazolin And Dextrose is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFAZOLIN AND DEXTROSE is cefazolin sodium. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin And Dextrose
A generic version of CEFAZOLIN AND DEXTROSE was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFAZOLIN AND DEXTROSE?
- What are the global sales for CEFAZOLIN AND DEXTROSE?
- What is Average Wholesale Price for CEFAZOLIN AND DEXTROSE?
Summary for CEFAZOLIN AND DEXTROSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 174 |
| Patent Applications: | 4,015 |
| DailyMed Link: | CEFAZOLIN AND DEXTROSE at DailyMed |
Recent Clinical Trials for CEFAZOLIN AND DEXTROSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hamilton Health Sciences Corporation | PHASE4 |
| Asan Medical Center | NA |
| Canadian Institutes of Health Research (CIHR) | PHASE4 |
Pharmacology for CEFAZOLIN AND DEXTROSE
| Drug Class | Cephalosporin Antibacterial |
US Patents and Regulatory Information for CEFAZOLIN AND DEXTROSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-002 | Jul 27, 2000 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-001 | Jul 27, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-003 | Jan 13, 2012 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-004 | Aug 26, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
